News & Events

Are Functional Foods ‘Therapeutic’? Insights from the EPO’s Latest Ruling

Abstract: EPO decision T 1396/23 confirms that functional foods can support medical‑use claims when their therapeutic effects are credible, data‑backed, and tied to recognised clinical outcomes. This provides some comfort to …

Read article

IP Ingredients: The IP in Personalized nutrItion

Personalised nutrition is the provision of dietary advice which is tailored to a person based on their individual characteristics and lifestyle.  As analytical techniques become faster and cheaper, and AI …

Read article

IP Ingredients: Winter Case Law Review 2025

A seasonal tasting of recent IP decisions across the UK and EU.  Including notes on what brand owners, creatives, R&D teams and food and drink businesses should take away. Patents …

Read article

IP Ingredients: The companies making – and patenting – alt coffee

How do you like your coffee? Frothy or flat? Milky or black? Oat-milk or soy?  How about coffee which isn’t derived from coffee beans? Coffee is the second most traded …

Read article

EU Customs Recordals

Read article

IP Ingredients: Summer Case Law Review 2025

As the British summer swings once again between sunburn and showers, it’s a great time to take stock of what the first half of the year has delivered by way …

Read article

IP Ingredients: What Will The EU’s Design Reform Package Do For Food & Drink Businesses?

As reported by our colleague Joanne Meredith in her recent post (click here to read), Phase One of the EU’s “Design Reform Package” became effective on 1 May 2025, with …

Read article

IP Ingredients: Why are food tech patent applications in Europe falling?

Number of European patent applications and grants in Food Chemistry In March 2025 the European Patent Office (EPO) published its Patent Index 2024 – an analysis of the number of …

Read article

IP Ingredients: How food companies are using IP to stay ahead of the GLP-1 curve

The impact of GLP-1 on the food and beverage sector GLP-1 agonists, best-known under the brand names Ozempic® and Wegovy®, are medicines used to treat type 2 diabetes and obesity. …

Read article